Seismic Therapeutic Closes $121M Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
📰 Codon Capital News
Codon Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Codon Capital. Real-time updates on events, politics, business and more.
FogPharma's $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs
FogPharma is preclinical, but not for long. The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs.
Source: medcitynews.com
Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program
Roche announced it will acquire Good Therapeutics, a Seattle-based preclinical biotech, for $250 million. The deal makes Roche responsible for developing and commercializing Good's lead program, which seeks to make oncology drugs that target PD-1 proteins more effective, such as Keytruda or Opdivo.
Bristol Myers Squibb Opdivo John Mulligan Good Therapeutics Bristol Myers Squibb Rivervest Venture Partners Codon Capital
Source: medcitynews.com
Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of D
Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage.Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow...
Source: pharmiweb.com
Ansa Biotechnologies Closes $68M Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Daniel Lin Arlow Sebastian Palluk Humboldt Fund Ansa Biotechnologies Northpond Ventures Blue Water Life Science Advisors
Source: finsmes.com